“Cyplexinol’s® protein complex…highlight a potentially new, orally bioavailable therapeutic for the effective treatment of osteoporosis.”
Clinical Assessment of Low-dose Osteoinductive Protein as a Stand-alone Regimen in Self-reported Osteoarthritis
“Cyplexinol® was statistically more effective than the placebo in treating the signs and symptoms of osteoarthritis in a weight-bearing joint (hip or knee).
“Cyplexinol®, which contains BMPs and growth factors, plus glucosamine and chondroitin, reduced joint pain and stiffness effectively in individuals with reduced joint function associated with osteoarthritis.”
2-Beta Coxatene™ – A New Ingredient for Joint Support
“The effectiveness of 2BCT… suggests a new therapeutic option for suffers of joint conditions, both those associated with and those not associated with OA. 2BCT may provide a novel and synergistic response to preserving joint homeostasis and improving quality of life.”